Taking Ozempic? A routine eye exam could help you understand your risk for vision loss.
Some research suggests that GLP-1 drugs may raise the risk of a rare eye disease that causes full or partial vision loss.

Glideslope AI-powered market news
No market stories in the last 7 days. The latest coverage is below.
No scored stories in the last 7 days.
| Day | Mood | Stories |
|---|---|---|
| Fri, Oct 9 | — | 0 |
| Thu, Oct 8 | — | 0 |
| Wed, Oct 7 | — | 0 |
| Tue, Oct 6 | — | 0 |
| Mon, Oct 5 | — | 0 |
| Sun, Oct 4 | — | 0 |
| Sat, Oct 3 | — | 0 |
| Fri, Oct 2 | — | 0 |
Some research suggests that GLP-1 drugs may raise the risk of a rare eye disease that causes full or partial vision loss.
Hundreds of Americans have filed personal injury lawsuits against the makers of popular diabetes and weight-loss drugs like Ozempic, Wegovy, and Mounjaro, clai…

Novo Nordisk stock tumbled on Monday as the weight-loss drug manufacturer failed to excite investors hoping for a turnaround.
People on medications for weight loss are buying less food, shrinking their portion sizes and purchasing smaller clothes. Businesses are trying to adjust.

The Danish drug giant behind Ozempic is competing with Eli Lilly in the market for weight-loss drugs.
Ozempic maker: We sold health when people wanted weight loss

Novo Nordisk's chief executive, Mike Doustdar, is a year into a corporate turnaround. He says investors are still underestimating the promise of the company's…

While Ozempic maker Novo Nordisk has fallen on tough times, Wall Street analysts have still been reluctant to advise investors to sell the stock, until Deutsch…
Side Effects of Ozempic Include Blindness and STOMACH PARALYSIS

The aestetics company hope increased GLP-1 use will fuel demand for treatments addressing facial volume loss, sometimes dubbed "Ozempic face."

Danish pharma company says Eli Lilly using outdated trial data to make its weight-loss drugs appear more effective. Ozempic maker Novo Nordisk said on Tuesday…

"Ozempic ears" are all the rage in plastic surgery these days. They seem to be the new side effect of using GLP-1 meds such as Ozempic and Wegovy. Apparently,…

This article is part of Upstream, The Daily Wire's new home for culture and lifestyle. Real human insight and human stories - from our featured writers to you.…

It's probably the Ozempic

Move over, Ozempic. There's a new weight loss shot everyone's freaking out about. A new experimental weight loss drug called "retatrutide" is suddenly blowing…

"This has been the best product launch in the last decade that we have seen."

New generics in Canada likely mark the start of a decline in international revenue of semaglutide, the active ingredient in Novo's Ozempic and Wegovy.

People are buying more Ice Breakers to combat "Ozempic breath."

Hershey says it's benefiting from the growing use of GLP-1 weight-loss drugs even as people cut down on snacks. Here's why.

Eau, eau, eau, Eau-zempic!

The freight market is no stranger to disruptive forces - tariffs, recessions, weather, economic fluctuations, and capacity crunches have all reshaped freight d…

In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for…

Drugmaker Novo Nordisk plans to slash list prices for its wildly popular weight-loss and diabetes drugs Wegovy and Ozempic by as much as 50%, according to a re…

Starting in 2027, the Danish pharma firm will sell its weight-loss and diabetes drugs for $675 per month.

Shares of Novo Nordisk and rival Eli Lilly fell on Tuesday after a report said price cuts are coming for popular weight-loss drugs.
Trump's Cuba Talks, Pritzker's Epstein Ties, Goldman Sachs DEI & McDonald's Ozempic Diet | PBD #741

McDonald's is the latest fast-food chain to jump on the GLP-1 train, testing new menu items to appeal to growing swaths of customers on the popular weight-loss…

The once high-flying Danish drugmaker has struggled to fend off rivals in the weight-loss industry and faces lower prices for its medicines under a deal with P…

'Clients bring back entire wardrobes': Tailors say Ozempic is reshaping Wall Street
Food companies are overhauling brands as they work to ditch artificial dyes or pack protein into their products. New U.S. dietary guidelines could speed up the…
Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.
LOG IN / SUBSCRIBE